Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and Chronic Obstructive Pulmonary Disease: An Analysis From the Platelet Inhibition and Patient Outcomes (PLATO) Trial

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 10, 2015-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

eNOS gene influences platelet phenotype in acute coronary syndrome patients on dual antiplatelet treatment

By Fatini Cinzia   Sticchi Elena   Bolli Paola   Marcucci Rossella   Giusti Betti   Paniccia Rita   Gori Anna Maria   Gensini Gian Franco   Abbate Rosanna  

Platelets, Vol. 20, Iss. 8, 2009-07 ,pp. : 548-554

Informa Healthcare

Access to resources Recommend Favorite

Increased risk of minor bleeding and antiplatelet therapy cessation in patients with acute coronary syndromes and low on-aspirin platelet reactivity. A prospective cohort study

By Huczek Zenon  

Journal of Thrombosis and Thrombolysis, Vol. 36, Iss. 1, 2013-07 ,pp. : 22-30

Springer Publishing Company

Access to resources Recommend Favorite

Prasugrel: A Novel Antiplatelet Therapy for Acute Coronary Syndromes

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 4, Iss. 3, 2009-11 ,pp. : 192-202

Bentham Science Publishers

Access to resources Recommend Favorite

Triple Therapy Versus Dual Antiplatelet Therapy for Patients with Atrial Fibrillation and Acute Coronary Syndromes: A Systematic Literature Review

By  

Current Cardiology Reviews, Vol. 13, Iss. 4, 2017-10 ,pp. : 325-333

Bentham Science Publishers

Access to resources Recommend Favorite